Melanoma Research Review, Issue 8

In this Issue:

AMLs in the United States
BRAF-V600E in primary nodular melanoma
and aggressive tumour features
German skin cancer screening program for melanoma
Prolonged benefit from ipilimumab predicts outcomes to subsequent pembrolizumab
Pembrolizumab and tumour response and OS among patients with advanced melanoma
BRAF mutation status in ctDNA of metastatic melanoma patients and clinical response
CLND vs no dissection in patients with SLN biopsy positive melanoma
Prevalence of MITF p.E318K and clinical implications in patients with melanoma
OS in patients with BRAF V600 – mutant metastatic melanoma receiving dabrafenib + tramentinib
UVA-irradiation induces melanoma invasion via enhanced Warburg effect

Please login below to download this issue (PDF)

Subscribe